Milwhite Launches Monthly Journal
Milwhite Inc. has always strived to provide our client’s needs in a timely and professional manner with a product that is of the highest quality. These needs are not only provided by our products from a physical/functional perspective but are often in the form of answers to questions about the specific products we produce as well as information about particular issues existing today within the dynamic feed and animal industries. It is because of the desire for information and requests during the past few years by many of our clients worldwide that Milwhite Inc. is launching a monthly communication, Milwhite’s Journal. By providing this communication of a one page format, our clients will quickly be brought up-to-date about our products as well as many of the topics often discussed in the areas of animal nutrition, management, production, health, etc.
About the Author
The person responsible for putting together this monthly communication and organization of its content will be Dr. Orlando Osuna, Director of Health Services for Milwhite, Inc. Also, Dr. Richard Miles, Professor Emeritus at the University of Florida will assist in the development of publications. Both are well known nationally and globally and are very capable of compiling short, easy to read, meaningful contributions to Milwhite’s Journal.
What to Expect
The first series of monthly communication in Milwhite’s Journal will be dedicated to one of our most successful products, Improved Milbond-TX® (IMTX). The development of IMTX from the original MTX took two years of intensive in-vitro and in-vivo testing to prove its efficacy and safety as a mycotoxin binder with a high affinity for aflatoxin and fumonisin. Milwhite, Inc. introduced IMTX to the feed and animal industries in 1992. Since its introduction as a mycotoxin binder, IMTX has been continually tested in animal studies involving broilers, egg-type laying hens, broiler breeders, piglets, dairy cows and salmon. To date, over 30 invivo studies have been conducted in 10 major universities located mostly in the United States. Data collected in these studies have not only provided required evidence of the efficacy and safety of using IMTX in animal diets, but beneficial expectations anticipated from dietary supplementation of this inert clay-based adsorbent. The university safety studies and the studies proving the efficacy of IMTX as a mycotoxin binder will be the focus of the first issues of Milwhite’s Journal. In subsequent issues, the wide-ranging additional benefits of adding IMTX to diets will be discussed along with many general and specific key topics concerning various areas of animal nutrition, management and production.